These data suggest that PTP1B inhibition might represent a novel therapeutic avenue for the treatment of diabetes associated endothelial dysfunction and might prevent diabetic macrovascular complications such as atherosclerosis and coronary heart disease. Here, PTPN1 is linked to atherosclerosis.